Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Stem Cell Research

Free Subscription Articles published in Oncogene Retrieve available abstracts of 38 articles: HTML format

Single Articles

December 2025
1. ESAKI N, Sakoda T, Ando R, Miyai Y, et al
   Meflin is a druggable target using antibody-drug conjugates in progressive osteosarcoma.
   Oncogene. 2025;44:4576-4586.
   PubMed     Abstract available
   
   
   October 2025
2. TANG S, Chen K, Zheng F, Fu Z, et al
   High serum LDL promotes EMT and stemness through LDLR/FOXQ1/NF-kappaB1 pathway in epithelial ovarian cancer.
   Oncogene. 2025 Oct 22. doi: 10.1038/s41388-025-03609.
   PubMed     Abstract available
   
   
   
3. YANG T, Zeng Y, Li Y, Huang Y, et al
   Par6/SOX2 interact to modulate stemness maintenance in glioma by regulating the EGFR/PI3K/AKT signaling cascade.
   Oncogene. 2025 Oct 11. doi: 10.1038/s41388-025-03595.
   PubMed     Abstract available
   
   
   September 2025
4. CHEN H, Zhou Y, Zhang Y, Fan Y, et al
   TRIM21-mediated ubiquitination of SIX2 attenuates breast cancer stemness via LGSN suppression.
   Oncogene. 2025 Sep 15. doi: 10.1038/s41388-025-03572.
   PubMed     Abstract available
   
   
   
5. CIVENNI G, Sandrini G, Merulla J, Musumeci C, et al
   Integrated control of cancer stemness by sigma(1) receptor in advanced prostate cancer.
   Oncogene. 2025 Sep 2. doi: 10.1038/s41388-025-03541.
   PubMed     Abstract available
   
   
   
6. LIU L, Chen S, Lei Y, Lin Z, et al
   REPS2 attenuates cancer stemness through inhibiting Wnt signaling by autophagy mediated degradation of beta-catenin.
   Oncogene. 2025;44:2942-2955.
   PubMed     Abstract available
   
   
   
7. LISBOA MO, Borgonovo T, Fracaro L, Rangel Pozzo A, et al
   Chromosomal abnormalities of mesenchymal stromal cells in hematological malignancies.
   Oncogene. 2025;44:3155-3170.
   PubMed     Abstract available
   
   
   August 2025
8. JIANG Z, Baechler BL, Li H, Lad H, et al
   The tumor suppressor pRb and its relative p130 are required to maintain murine adult skeletal muscle homeostasis.
   Oncogene. 2025;44:2662-2674.
   PubMed     Abstract available
   
   
   July 2025
9. GUO L, Rao Y, Song Y, Hu J, et al
   SIX1 transmits signals for breast cancer progression via the ZEB1/IL6/STAT3 signaling axis.
   Oncogene. 2025 Jul 26. doi: 10.1038/s41388-025-03499.
   PubMed     Abstract available
   
   
   
10. HUO D, Si M, Yu K, Fang X, et al
    Increased antiandrogen enzalutamide sensitivity via altering prostate cancer stem cell traits through modulating the androgen receptor-mediated CDR1/circCDR1-AS/miR-1290/BMP4 signaling.
    Oncogene. 2025 Jul 4. doi: 10.1038/s41388-025-03482.
    PubMed     Abstract available
    
    
    June 2025
11. LI X, Zhao H, Jiang E, Liu P, et al
    ITGB1/FERMT1 mechanoactivation enhances CD44 characteristic stemness in oral squamous cell carcinoma via ubiquitin-dependent CK1alpha degradation.
    Oncogene. 2025;44:1530-1544.
    PubMed     Abstract available
    
    
    
12. WANG X, Yu L, Zhou X, Chung GT, et al
    Characterizing resistant cellular states in nasopharyngeal carcinoma during EBV lytic induction.
    Oncogene. 2025;44:1805-1819.
    PubMed     Abstract available
    
    
    May 2025
13. EL-SEHEMY A, Tachibana N, Ortin-Martinez A, Ringuette D, et al
    Importin-alpha transports Norrin to the nucleus to promote proliferation and Notch signaling in glioblastoma stem cells.
    Oncogene. 2025 May 27. doi: 10.1038/s41388-025-03427.
    PubMed     Abstract available
    
    
    
14. CHEN W, Wang YJ
    Multifaceted roles of OCT4 in tumor microenvironment: biology and therapeutic implications.
    Oncogene. 2025;44:1213-1229.
    PubMed     Abstract available
    
    
    April 2025
15. LIU X, Cui Y, Gong J, Yu X, et al
    SETD5 facilitates stemness and represses ferroptosis via m6A-mediating PKM2 stabilization in non-small cell lung cancer.
    Oncogene. 2025 Apr 30. doi: 10.1038/s41388-025-03426.
    PubMed     Abstract available
    
    
    
16. REN F, Yi Y, Lu T, Liu X, et al
    Synthetic lethality through Gsk3beta inhibition in glioma stem cells via the WNT-WWC1-YAP axis.
    Oncogene. 2025 Apr 23. doi: 10.1038/s41388-025-03418.
    PubMed     Abstract available
    
    
    
17. YANG X, Liu R, Jin J, Xv J, et al
    Cancer stem cells-derived exosomal TSPAN8 enhances non-stem cancer cells stemness and promotes malignant progression in PDAC.
    Oncogene. 2025 Apr 18. doi: 10.1038/s41388-025-03412.
    PubMed     Abstract available
    
    
    March 2025
18. WANG J, Yang F, Chen Y, Xing Y, et al
    A positive feedback loop of OTUD1 and c-Jun driven by leptin expedites stemness maintenance in ovarian cancer.
    Oncogene. 2025 Mar 19. doi: 10.1038/s41388-025-03342.
    PubMed     Abstract available
    
    
    December 2024
19. GILLESPIE MS, Chiang K, Regan-Mochrie GL, Choi SY, et al
    PRMT5-regulated splicing of DNA repair genes drives chemoresistance in breast cancer stem cells.
    Oncogene. 2024 Dec 18. doi: 10.1038/s41388-024-03264.
    PubMed     Abstract available
    
    
    
20. TANG T, Yang T, Xue H, Liu X, et al
    Breast cancer stem cell-derived exosomal lnc-PDGFD induces fibroblast-niche formation and promotes lung metastasis.
    Oncogene. 2024 Dec 4. doi: 10.1038/s41388-024-03237.
    PubMed     Abstract available
    
    
    November 2024
21. SUN B, Wang G, Chen G, Zhang Y, et al
    GNAO1 overexpression promotes neural differentiation of glioma stem-like cells and reduces tumorigenicity through TRIM21/CREB/HES1 axis.
    Oncogene. 2024 Nov 23. doi: 10.1038/s41388-024-03234.
    PubMed     Abstract available
    
    
    
22. DUAN C, Lin X, Zou W, He Q, et al
    Targeting DDX3X eliminates leukemia stem cells in chronic myeloid leukemia by blocking NT5DC2 mRNA translation.
    Oncogene. 2024 Nov 8. doi: 10.1038/s41388-024-03215.
    PubMed     Abstract available
    
    
    
23. ZHANG C, Hao T, Bortoluzzi A, Chen MH, et al
    Sex-dependent differences in hematopoietic stem cell aging and leukemogenic potential.
    Oncogene. 2024 Nov 1. doi: 10.1038/s41388-024-03197.
    PubMed     Abstract available
    
    
    
24. ANTOON R, Overdevest N, Saleh AH, Keating A, et al
    Mesenchymal stromal cells as cancer promoters.
    Oncogene. 2024;43:3545-3555.
    PubMed     Abstract available
    
    
    October 2024
25. REISSLAND M, Hartmann O, Tauch S, Bugter JM, et al
    USP10 drives cancer stemness and enables super-competitor signalling in colorectal cancer.
    Oncogene. 2024 Oct 23. doi: 10.1038/s41388-024-03141.
    PubMed     Abstract available
    
    
    September 2024
26. FERNANDO W, Cruickshank BM, Arun RP, MacLean MR, et al
    ALDH1A3 is the switch that determines the balance of ALDH(+) and CD24(-)CD44(+) cancer stem cells, EMT-MET, and glucose metabolism in breast cancer.
    Oncogene. 2024 Sep 9. doi: 10.1038/s41388-024-03156.
    PubMed     Abstract available
    
    
    
27. GRASSET EM, Deshpande A, Lee JW, Cho Y, et al
    Mapping the breast tumor microenvironment: proximity analysis reveals spatial relationships between macrophage subtypes and metastasis-initiating cancer cells.
    Oncogene. 2024;43:2927-2937.
    PubMed     Abstract available
    
    
    August 2024
28. SONG Y, Zhang Y, Wang Z, Lin Y, et al
    CCL2 mediated IKZF1 expression promotes M2 polarization of glioma-associated macrophages through CD84-SHP2 pathway.
    Oncogene. 2024 Aug 7. doi: 10.1038/s41388-024-03118.
    PubMed     Abstract available
    
    
    
29. HU J, Li X, Xu K, Chen J, et al
    CircVPS8 promotes the malignant phenotype and inhibits ferroptosis of glioma stem cells by acting as a scaffold for MKRN1, SOX15 and HNF4A.
    Oncogene. 2024 Aug 4. doi: 10.1038/s41388-024-03116.
    PubMed     Abstract available
    
    
    
30. SERGIO I, Varricchio C, Patel SK, Del Gaizo M, et al
    Notch3-regulated microRNAs impair CXCR4-dependent maturation of thymocytes allowing maintenance and progression of T-ALL.
    Oncogene. 2024;43:2535-2547.
    PubMed     Abstract available
    
    
    July 2024
31. LEE DOOLITTLE WK, Zhu X, Park S, Zhu YJ, et al
    Correction: Regulation of cancer stem cell activity by thyroid hormone receptor beta.
    Oncogene. 2024 Jul 17. doi: 10.1038/s41388-024-03106.
    PubMed    
    
    
    June 2024
32. WANG G, Zhang W, Ren J, Zeng Y, et al
    The DNA damage-independent ATM signalling maintains CBP/DOT1L axis in MLL rearranged acute myeloid leukaemia.
    Oncogene. 2024;43:1900-1916.
    PubMed     Abstract available
    
    
    May 2024
33. LI W, Huang C, Qiu L, Tang Y, et al
    p52-ZER6/IGF1R axis maintains cancer stem cell population to promote cancer progression by enhancing pro-survival mitophagy.
    Oncogene. 2024 May 21. doi: 10.1038/s41388-024-03058.
    PubMed     Abstract available
    
    
    
34. LU Y, Chen D, Wang B, Chai W, et al
    Single-cell landscape of undifferentiated pleomorphic sarcoma.
    Oncogene. 2024;43:1353-1368.
    PubMed     Abstract available
    
    
    
35. JIANG H, Wang L, Zhang Q, Wang S, et al
    Bone marrow stromal cells dictate lanosterol biosynthesis and ferroptosis of multiple myeloma.
    Oncogene. 2024;43:1644-1653.
    PubMed     Abstract available
    
    
    April 2024
36. DOHENY D, Sirkisoon S, Carpenter RL, Aguayo NR, et al
    Correction: Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis.
    Oncogene. 2024 Apr 27. doi: 10.1038/s41388-024-03046.
    PubMed    
    
    
    
37. CHEN H, Lee LJ, Vincent KM, Xu Z, et al
    Transcription factor ZIC2 regulates the tumorigenic phenotypes associated with both bulk and cancer stem cells in epithelial ovarian cancer.
    Oncogene. 2024 Apr 9. doi: 10.1038/s41388-024-03026.
    PubMed     Abstract available
    
    
    November 2023
38. CHEN W, Wang F, Yu X, Qi J, et al
    LncRNA MIR31HG fosters stemness malignant features of non-small cell lung cancer via H3K4me1- and H3K27Ace-mediated GLI2 expression.
    Oncogene. 2023 Nov 10. doi: 10.1038/s41388-023-02883.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Stem Cell Research is free of charge.